DK1815853T3 - Terapeutisk middel (-)-(BPAP) mod stofafhængighed - Google Patents

Terapeutisk middel (-)-(BPAP) mod stofafhængighed

Info

Publication number
DK1815853T3
DK1815853T3 DK05809728T DK05809728T DK1815853T3 DK 1815853 T3 DK1815853 T3 DK 1815853T3 DK 05809728 T DK05809728 T DK 05809728T DK 05809728 T DK05809728 T DK 05809728T DK 1815853 T3 DK1815853 T3 DK 1815853T3
Authority
DK
Denmark
Prior art keywords
therapeutic agent
substance
substance dependence
bpap
craving
Prior art date
Application number
DK05809728T
Other languages
English (en)
Inventor
Fumio Yoneda
Kazuhiko Morimoto
Tsuneyuki Yamamoto
Original Assignee
Univ Kyushu Nat Univ Corp
Fujimoto Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyushu Nat Univ Corp, Fujimoto Co Ltd filed Critical Univ Kyushu Nat Univ Corp
Application granted granted Critical
Publication of DK1815853T3 publication Critical patent/DK1815853T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK05809728T 2004-11-25 2005-11-21 Terapeutisk middel (-)-(BPAP) mod stofafhængighed DK1815853T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004339996A JP5030194B2 (ja) 2004-11-25 2004-11-25 薬物依存症治療剤
PCT/JP2005/021344 WO2006057211A1 (ja) 2004-11-25 2005-11-21 薬物依存症治療剤

Publications (1)

Publication Number Publication Date
DK1815853T3 true DK1815853T3 (da) 2009-08-03

Family

ID=36497948

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05809728T DK1815853T3 (da) 2004-11-25 2005-11-21 Terapeutisk middel (-)-(BPAP) mod stofafhængighed

Country Status (15)

Country Link
US (2) US7825158B2 (da)
EP (1) EP1815853B1 (da)
JP (1) JP5030194B2 (da)
KR (1) KR101096416B1 (da)
CN (1) CN101065123B (da)
AT (1) ATE429219T1 (da)
AU (1) AU2005308258B2 (da)
CA (1) CA2589289C (da)
DE (1) DE602005014135D1 (da)
DK (1) DK1815853T3 (da)
ES (1) ES2325790T3 (da)
HK (1) HK1113309A1 (da)
IL (1) IL183028A (da)
SI (1) SI1815853T1 (da)
WO (1) WO2006057211A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2158908B1 (en) * 2007-06-21 2013-04-24 Fujimoto Co., Ltd. Composition for transdermal administration
CN106163514B (zh) 2013-12-25 2019-07-19 藤本株式会社 注意缺陷和多动性障碍的预防及治疗剂
CA2968793C (en) 2014-12-05 2022-02-08 Semmelweis University Compounds for use in the prevention or treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003801A1 (en) 1986-11-21 1988-06-02 Glaxo Group Limited Medicaments for treatment or prevention of withdrawal syndrome
JPH03500411A (ja) 1987-10-07 1991-01-31 マトリックス テクノロジーズ インコーポレーテッド コカイン中毒の処置および治療薬
DE3930282A1 (de) 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit
JP3601898B2 (ja) 1996-02-14 2004-12-15 俊隆 鍋島 薬物依存形成抑制剤
JPH1129476A (ja) 1997-05-16 1999-02-02 Grelan Pharmaceut Co Ltd 麻薬依存抑制剤
JP4499208B2 (ja) * 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
JP4691230B2 (ja) * 2000-04-11 2011-06-01 株式会社フジモト・コーポレーション 光学活性1−(ベンゾフラン−2−イル)−2−プロピルアミノペンタンの製造方法
JP4953041B2 (ja) * 2001-09-19 2012-06-13 株式会社フジモト・コーポレーション アポトーシス抑制剤
JP4953040B2 (ja) * 2001-09-19 2012-06-13 株式会社フジモト・コーポレーション アポトーシス抑制剤

Also Published As

Publication number Publication date
EP1815853A1 (en) 2007-08-08
US7825158B2 (en) 2010-11-02
WO2006057211A1 (ja) 2006-06-01
CN101065123A (zh) 2007-10-31
CA2589289A1 (en) 2006-06-01
CA2589289C (en) 2013-04-30
ATE429219T1 (de) 2009-05-15
ES2325790T3 (es) 2009-09-17
EP1815853B1 (en) 2009-04-22
IL183028A0 (en) 2007-10-31
AU2005308258A1 (en) 2006-06-01
IL183028A (en) 2011-12-29
US20100298426A1 (en) 2010-11-25
CN101065123B (zh) 2012-02-15
KR101096416B1 (ko) 2011-12-21
KR20070091610A (ko) 2007-09-11
DE602005014135D1 (de) 2009-06-04
US20080004337A1 (en) 2008-01-03
SI1815853T1 (sl) 2009-10-31
US8318799B2 (en) 2012-11-27
AU2005308258B2 (en) 2011-02-24
EP1815853A4 (en) 2008-03-19
JP2006151820A (ja) 2006-06-15
HK1113309A1 (en) 2008-10-03
JP5030194B2 (ja) 2012-09-19

Similar Documents

Publication Publication Date Title
EA200601313A1 (ru) Варианты участка f
NL1028947A1 (nl) Gesubstitueerde methylaryl- of heteroarylamideverbindingen.
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
EA200702549A1 (ru) Способ производства органического соединения
MY145556A (en) Method for purifying hydrogen chloride
BRPI0607762B8 (pt) análogos de glp-1, composição farmacêutica contendo os mesmos e uso de um composto
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
NL1028948A1 (nl) Ortho gesubstitueerde aryl- of heteroarylamideverbindingen.
BR122012023120B8 (pt) Composto inibidor da recaptação de serotonina
TW200621937A (en) New compound and organic light emitting device using the same
CR10157A (es) Compuestos químicos
CY1113320T1 (el) Σπειρο-κυκλικα νιτριλια ως αναστολεις πρωτεασης
CO5601045A2 (es) Procedimiento para la fabricacion de compuestos organicos
WO2007004092A3 (en) Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates
DK1815853T3 (da) Terapeutisk middel (-)-(BPAP) mod stofafhængighed
CY1110688T1 (el) Διεργασια για την παρασκευη καρβεδιλολης και εναντιομερων αυτης
TW200621843A (en) Solvent composition
ATE465153T1 (de) Neue indazolverbindungen mit kondensiertem ring
DE602004019698D1 (de) Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin
CY1108865T1 (el) Υποκατεστημενες 2,5-διαμινομευθυλο-1η-πυρρολες
ITMI20041211A1 (it) Catalizzatori a base di complessi metallici per la sintesi di acido crisantemico otticamente attivo
EA200601090A1 (ru) Получение 2,3-цис-замещённых 2-арилпропеналей
RU2007134356A (ru) Способ снижения уровня тревожности в эксперименте
EA200900479A1 (ru) СПОСОБ ПОЛУЧЕНИЯ γ-БУТИРОЛАКТОНОВ